Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "CHI"

5468 News Found

Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru
Hospitals | April 14, 2026

Aster DM Healthcare invests Rs 96 crore to add 159-bed specialised Aster Women & Children centre in Bengaluru

With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds


Ankura Hospitals strengthens pediatric center of excellence as complex child cases rise
Hospitals | April 13, 2026

Ankura Hospitals strengthens pediatric center of excellence as complex child cases rise

Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care


Mumbai’s Apex Hospital achieves landmark 607 knee replacement surgeries in FY26
Hospitals | April 11, 2026

Mumbai’s Apex Hospital achieves landmark 607 knee replacement surgeries in FY26

The event also featured discussions on emerging trends in joint replacement surgery


Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE
News | April 11, 2026

Orchid Pharma submits Q4 FY26 SEBI compliance certificate to NSE, BSE

Routine regulatory filing confirms completion of demat and share transfer compliances for March quarter


Biocon appoints Mandar Ghatnekar as Chief Technology Officer
People | April 10, 2026

Biocon appoints Mandar Ghatnekar as Chief Technology Officer

Former Global Head of IT & Digital Transformation at Biocon Biologics steps into enterprise-wide technology leadership role


Exclusive | Bharat Biotech’s ROTAVAC halves severe diarrhoea hospitalisations in children, landmark Nature study confirms
Biopharma | April 10, 2026

Exclusive | Bharat Biotech’s ROTAVAC halves severe diarrhoea hospitalisations in children, landmark Nature study confirms

Nature Medicine study delivers strongest real-world evidence yet for India’s indigenous rotavirus vaccine under UIP


University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders
Hospitals | April 09, 2026

University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders

Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust


Chiba University study flags allergy risk in high-binding antibody drugs
Biopharma | April 09, 2026

Chiba University study flags allergy risk in high-binding antibody drugs

For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms


Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
Biopharma | April 07, 2026

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline